Who makes DAPT intensification?

DAPT intensification is developed by Kaiser Franz Josef Hospital.

What development phase is DAPT intensification in?

DAPT intensification is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

DAPT intensification

Kaiser Franz Josef Hospital · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	DAPT intensification
Sponsor	Kaiser Franz Josef Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The IDEAL-PCI Extended Registry (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DAPT intensification CI brief — competitive landscape report
DAPT intensification updates RSS · CI watch RSS
Kaiser Franz Josef Hospital portfolio CI